Skip to main content

Table 4 Primary outcomes on blood pressures using the modified intention-to-treat analysis

From: Treatment of obstructive sleep apnea in high risk pregnancy: a multicenter randomized controlled trial

Modified intention-to-treat analysis

Mean (SE)a

CPAP (n = 153)

Usual-care (n = 157)

Overall mean

Intergroup difference (95%CI)c

p value

Adjusted intergroup difference (95%CI)d

p value

18–20 weeksb

24–28 weeks

32–34 weeks

18–20 weeksb

24–28 weeks

32–34 weeks

CPAP vs control

SBP

114.7 (1.0)

112.5 (1.0)

115.2 (1.0)

116.7 (1.0)

114.4 (1.0)

117.2 (1.0)

114.1 (1.0)

116.1 (0.9)

− 1.9 (− 4.5, 0.6)

0.148

− 2.08 (− 4.41, 0.26)

0.082

DBP

70.4 (0.7)

69.3 (0.7)

71.3 (0.7)

72.6 (0.7)

71.5 (0.7)

73.8 (0.7)

70.4 (0.6)

72.5 (0.6)

− 2.2 (− 3.9, − 0.4)

0.014

− 2.22 (− 3.70, − 0.75)

0.003

MAP

85.2 (0.8)

83.7 (0.8)

86.0 (0.8)

87.3 (0.7)

85.8 (0.7)

88.0 (0.7)

85.0 (0.7)

87.0 (0.7)

− 2.1 (− 3.9, − 0.2)

0.034

− 2.17 (− 3.83, − 0.52)

0.010

  1. CPAP continuous positive airway pressure; DBP diastolic blood pressure; MAP mean arterial pressure; SBP systolic blood pressure; SE standard error; 95%CI 95% confidence interval
  2. aPrimary outcome on systolic and diastolic blood pressures are shown as means and SE estimated at each time point from the mixed-effect linear regression
  3. bBlood pressure data during 18–20 weeks gestation from participants who were randomized during 2nd trimester in both CPAP (n = 6) and usual-care groups (n = 6) were not included in the analyses
  4. cIntergroup difference is calculated as difference of marginal means (overall mean) between CPAP compared to the usual-care groups using mixed-effect linear regression model after randomization presented as mean difference and 95% CI
  5. dAdjusted intergroup difference is calculated as difference of marginal mean between CPAP compared to the usual-care groups using a mixed-effect linear regression model after randomization presented as mean difference and 95%CI adjusted with underlying chronic hypertension status, anti-hypertensive medication use and gestational age